Suno Secures $400 Million in Latest Series E Funding Round
Suno secured $400 million in its latest Series E, adding another data point to the Healthcare & Life Sciences funding market.
Suno Raises $400 million in Funding
Suno is a the United States, is an AI music generation platform that enables users to create full songs from text prompts. The company has raised-based Digital Health company focused on use the funds to develop AI music generation technology and expand its partnerships with major record labels.
Investors Behind the Funding
The round was backed by Co-founder. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.
Company Profile and Market Context
Suno operates in Healthcare & Life Sciences. Suno's Series E round shows investors are still backing digital health platforms with real scale narratives. At $400M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.
Strategic Use of Funds
use the funds to develop AI music generation technology and expand its partnerships with major record labels
Looking Ahead
Suno Raises $400M Series E
Source reference: original announcement/article.
View Suno's full profile and funding history on Funding Intelligence →